Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC)

被引：0
|
作者：
Emanuele Vita
Alessio Stefani
Geny Piro
Luca Mastrantoni
Marco Cintoni
Giuseppe Cicchetti
Ileana Sparagna
Federico Monaca
Guido Horn
Jacopo Russo
Diletta Barone
Mariantonietta Di Salvatore
Rocco Trisolini
Filippo Lococo
Ciro Mazzarella
Alessandra Cancellieri
Carmine Carbone
Anna Rita Larici
Maria Cristina Mele
Sara Pilotto
Michele Milella
Giampaolo Tortora
Emilio Bria
机构：
[1] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,UOSD Oncologia Toraco
[2] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Polmonare, Comprehensive Cancer Center
[3] Università Cattolica del Sacro Cuore,UOC Oncologia Medica, Comprehensive Cancer Center
[4] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,UOC Nutrizione Clinica
[5] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,UOC Radiologia Toracica e Cardiovascolare, Advanced Radiodiagnostics Center
[6] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,UOC Pneumologia Interventistica
[7] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,UOC Chirurgia Toracica
[8] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,UOC Radioterapia Oncologica
[9] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,UOC Anatomia Patologica
[10] Verona University Hospital Trust,UOC Oncologia Medica
来源：
Cancer Immunology, Immunotherapy | 2023年 / 72卷
关键词：
SCLC; Immunotherapy; Metabolomics; Leptin; Adipokines; Obesity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3803 / 3812
页数：9
相关论文
共 45 条
  • [1] Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC)
    Vita, Emanuele
    Stefani, Alessio
    Piro, Geny
    Mastrantoni, Luca
    Cintoni, Marco
    Cicchetti, Giuseppe
    Sparagna, Ileana
    Monaca, Federico
    Horn, Guido
    Russo, Jacopo
    Barone, Diletta
    Di Salvatore, Mariantonietta
    Trisolini, Rocco
    Lococo, Filippo
    Mazzarella, Ciro
    Cancellieri, Alessandra
    Carbone, Carmine
    Larici, Anna Rita
    Mele, Maria Cristina
    Pilotto, Sara
    Milella, Michele
    Tortora, Giampaolo
    Bria, Emilio
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (11) : 3803 - 3812
  • [2] Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis
    Sathiyapalan, Arani
    Febbraro, Michela
    Pond, Gregory R.
    Ellis, Peter M.
    CURRENT ONCOLOGY, 2022, 29 (12) : 9046 - 9065
  • [3] Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
    Gadgeel, Shirish M.
    Pennell, Nathan A.
    Fidler, Mary Jo
    Halmos, Balazs
    Bonomi, Philip
    Stevenson, James
    Schneider, Bryan
    Sukari, Ammar
    Ventimiglia, Jaclyn
    Chen, Wei
    Galasso, Cathy
    Wozniak, Antoinette
    Boerner, Julie
    Kalemkerian, Gregory P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : 1393 - 1399
  • [4] Use of radiation therapy among patients with Extensive-stage Small-cell lung cancer receiving Immunotherapy: Canadian consensus recommendations
    Sun, Alexander
    Abdulkarim, Bassam
    Blais, Normand
    Greenland, Jonathan
    Louie, Alexander V.
    Melosky, Barbara
    Schellenberg, Devin
    Snow, Stephanie
    Liu, Geoffrey
    LUNG CANCER, 2023, 179
  • [5] The Survival Analysis of Immunotherapy in a Real-Word Cohort of Women Patients with Extensive-Stage Small Cell Lung Cancer
    He, Y.
    Wang, Y.
    Jia, B.
    Wang, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S694 - S694
  • [6] Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as fi rst-line therapy for extensive-stage small-cell - cell lung cancer (ES-SCLC): a phase II trial
    Chen, Dawei
    Zou, Bing
    Li, Butuo
    Gao, Aiqin
    Huang, Wei
    Shao, Qian
    Meng, Xiangjiao
    Zhang, Pinliang
    Tang, Xiaoyong
    Hu, Xudong
    Zhang, Yan
    Guo, Jun
    Zhao, Changhong
    Yuan, Jiajia
    Li, Qian
    Zhu, Changbin
    Yu, Jinming
    Wang, Linlin
    ECLINICALMEDICINE, 2024, 75
  • [7] Clinical Outcomes of Continuous Immunotherapy Beyond Progression in Patients with Extensive-Stage Small Cell Lung Cancer
    Wang, C.
    Xuan, T.
    Wang, Y.
    Yang, C.
    Zhang, R.
    Zhao, W.
    Li, C.
    Cong, L.
    Meng, X.
    Li, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S668 - S668
  • [8] Development of a prognostic model for patients with extensive-stage small cell lung cancer undergoing immunotherapy and chemotherapy
    Gao, Yunbin
    Zhang, Lixia
    Yan, Meng
    Sun, Zongwen
    Zhao, Haibo
    Zhao, Lujun
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [9] Consolidative and salvage thoracic radiotherapy (TRT) in extensive-stage small-cell lung cancer (ES-SCLC) with first-line chemoimmunotherapy: a retrospective study from a single cancer center
    Lan, Aihua
    Dong, Huiling
    Zheng, Zhiqin
    Chu, Xiao
    Zhu, Zhengfei
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2025, 55
  • [10] Benefit of Consolidation Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer Patients Treated with Immunotherapy: Data from Slovenian Cohort
    Caks, Marina
    Janzic, Urska
    Rutar, Tjasa
    Unk, Mojca
    Demsar, Ana
    Mohorcic, Katja
    Turnsek, Nina
    Matos, Erika
    But-Hadzic, Jasna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (08)
12345